Medication keeps more patients with ANCA-associated vasculitis in remission than steroids

Avacopan, which targets a receptor that attracts the cells that cause inflammation, was shown to be more effective at keeping patients in remission for a year than prednisone.

from Top Health News -- ScienceDaily https://ift.tt/3qx3v26

Comments

Popular posts from this blog

New target to improve response to cancer immunotherapy

New 3D imaging and visualization technique provides detailed views of muscle architecture